Ann: Race raises $29.7 million in oversubscribed SPP, page-186

Ah yes, there is the pathetic response I’ve been waiting for.

I’ve been a part of this forum for a year, buying big and making RAC the biggest investment in my portfolio, sharing research articles and breaking them down to everyday shareholders on HC.

As soon as I mention “sell” and post something negative about your leader? I’m an enemy of the state. As if selling today has any impact, reducing price by $0.01 and market cap by 1M, when this is going to be a multi-billion company with price in $20’s?

The most pathetic part of your response is your “worrying “ about sick people.

This is a speculative biotechnology company conducting research mainly and treating a handful of people. Don’t get ahead of yourself, you’re here for the $$$, not helping cancer patients. Have a moral compass, if you cared you’d be donating to them directly or to cancer institutes not investing on a publicly listed company for profit.

At least I’m honest, I’m here for the science and scientists while making money. FTO precision oncology targets a low % of cancers and is years away from saving lives.

The lives that it might save are the ones in a few years when it’s distributed and FTO detection mechanisms become more advanced. A huge amount of people RAC are targeting will be dead by then.

If you want to help them, go and donate for their treatments. Don’t use a speculative small cap biotech company investment to make yourself feel better about saving lives just to help yourself sleep better. This company, like all small biotechs, is still highly speculative and anything could happen, your money could go down the drain and it might not be able to help any more cancerous patients. Nothing is a 100% certainty.

If I took my money out of RAC and put it into another speculative biotech company competitor, you’d be up in arms and telling me I’m a certified down ramper. When ultimately it’s the exact same thing, and if your moral, ethical code was consistent you’d be supporting me increase the share price and market cap of another cancer research company, but you won’t because of cult-like mentality.